This is a descriptive cross-sectional study, which aimed to analyze the health related quality of life (HRQoL) and its relationship with gender, age, duration and indication for the use of oral anticoagulants. A total of 178 patients were interviewed and the HRQoL was assessed through eight domains of the SF-36. The descriptive statistics used were, the Student's t, ANOVA and Tukey's tests for the comparison of the means between the groups. The indication for use was predominantly the metallic prosthetic heart valve (50%) with warfarin the most widely prescribed anticoagulant (83.3%). 
Introduction
Some cardiovascular diseases precipitate an unwanted blood coagulation action requiring the use of oral anticoagulants (OACs). The clinical applications of OACs have been evidenced through studies of various conditions, such as atrial fibrillation, venous thromboembolism, patients with prosthetic heart valves, congestive heart failure, myocardial infarction and other special situations (1) . The therapeutic action of the OAC can be influenced by numerous conditions that alter its absorption and metabolism. The intake of foods rich in fats and vitamin K, drugs containing acetylsalicylic acid and alcohol can be cited as examples. The changes in the desired levels of blood anticoagulation can cause hemorrhagic or thromboembolic events, harming the patient (1) . For the evaluation of the anticoagulation levels, laboratory control is accomplished through frequent blood sampling in order to obtain the International Normalized Ratio (INR) (2) www.eerp.usp.br/rlae Corbi ISA, Dantas RAS, Pelegrino FM, Carvalho ARS.
The use of OACs requires some care in order to control the desirable levels of blood coagulation and to prevent hemorrhagic and thromboembolic complications.
Such care can lead to changes in the lifestyle of users since this involves changes in the dietary habits, the use of alcohol and the performance of physical activity (5) (6) , as well as the overload caused by new tasks related to the use of medication, such as the habit of daily ingestion of the medication and the need for frequent visits to health services for monitoring of the anticoagulation range, and the fear of complications such as bleeding and thrombus formation (7) . All these changes caused by the use of the drug may impair the quality of life of the patient. The term health related quality of life (HRQoL) has been used when the concern of researchers is to investigate the influence of the disease and treatment on the quality of life of the individual (8) . This narrower concept has been used to avoid ambiguity between the definition of quality of life in the common sense and that used in clinical and medical trials, which is the focus of this study.
The evaluation of patients regarding the effects of the use of oral anticoagulants also deserves investigation.
A study published in the early 1990s (5) has already pointed out the negative effects of oral anticoagulants in the evaluation of the health status of the patients, when related to the presence of collateral effects of the medication. The fear of the occurrence of bleeding also caused increased anxiety in those individuals who had experienced this complication of the treatment. In oral anticoagulation therapy, as in other therapies for chronic conditions, the acceptance of the individuals, with reference to changing habits and behaviors, is necessary to be able to prevent later complications. Therefore, the success of each therapy depends on how each individual perceives its benefits (5) . Positive perceptions are related to a better control of the oral anticoagulation therapy and better HRQoL (6) , with the reduction of the number of oral anticoagulation therapy complications associated with improved HRQoL (1) .
In order to study the HRQoL of the users of oral anticoagulants, authors have used different types of instruments. Some authors used a measurement of HRQoL obtained through the generic instrument the Medical Outcomes Survey 36-item Short Form (SF-36) (6, (9) (10) (11) (12) and found that the more impaired HRQoL domains were Physical aspects and Vitality (6, 10) , Pain (11) , Physical functioning and General health status (6) . In Brazil, in a study that followed patients for the first six months of oral anticoagulation therapy, the author found that the mean values of the SF-36 domains ranged from 32.4 (Physical aspects) to 82.7 (Social aspects) at the beginning of the treatment. Six months after the beginning of the OAC therapy, the means of the domains were higher and ranged from 72.1 (Vitality) to 90.7 (Social aspects) (12) .
The measurement of HRQoL obtained by the SF-36 was also used in a study that evaluated the psychometric properties of an adherence instrument, aimed at patients using OACs (13) . In a literature review regarding specific instruments available to evaluate the HRQoL of patients using OACs, the authors identified only seven instruments (14) . In Brazil, one of these instruments, the Duke Anticoagulation Satisfaction Scale (11) , was recently validated (15) , and its use permitted the finding of improvements in the HRQoL six months after starting treatment, especially in the Psychological impact domain (12) .
The HRQoL of patients using OAC and the quality of the oral anticoagulation therapy have been associated with sociodemographic (age and gender) and clinical variables (indication for and the duration of the oral anticoagulation therapy) (6, 12, 16) . In the clinical practice of nurses, they are increasingly faced with patients using OAC under their care. A better understanding of the profile of these individuals and the impact of this therapy on the HRQoL will contribute to better planning of this care. Considering the scarcity of published Brazilian studies that investigate the HRQoL of patients receiving oral anticoagulation (12) , this study proposed to answer Survey 36-Item Short-Form (SF-36) (17) , in its validated Portuguese version (18) . This instrument consists of 36 items, of which 35 items are grouped into eight domains: Each domain presents values on a scale of zero to 100, with higher values indicating better perceived health status or HRQoL (18) . In the present study, the Cronbach's alpha values obtained ranged from 0.97 (Emotional aspects) to 0.69 (Social aspects), indicating good internal consistency of the items in the group studied.
The data were analyzed using the program 
Discussion
The present study verified a greater participation of women using oral anticoagulants, a result similar to that found by other investigators (6, 12, 16) , however, in other studies, researchers have mainly evaluated males (5, 11, 15, (19) (20) . The group was composed of subjects of various ages, with 40% over 60 years of age. Similar results were found in other studies (16, (19) (20) (21) (22) . It should be noted that the site in which the study was conducted is a tertiary level public hospital, characterized by its care, teaching and research activities. In this hospital, the majority of patients are attended in the Brazilian National Health System (SUS), being a reference for various specialties, including outpatient oral anticoagulation therapy, serving this region of São Paulo State. Thus, this data would justify the majority of the individuals having low schooling levels (mean 4.6 years of formal study). Among the studies reviewed, few refer to this data in the characterization of their participants, however, in those that have included such information, it was found that the participants presented higher education levels than the participants of this study (6, 11, 16) . The two main indications for oral anticoagulant use among the study subjects were the use of metallic prosthetic heart valves (50.6%) and the presence of atrial fibrillation (33.1%), with these indications also prevalent in other populations investigated (6, 12, 20) . Other studies have found the prevalence of various indications, including: as a result of acute myocardial infarction (11) and the presence of a pacemaker (10) . These indications were also present in this study, however, due to the low frequency observed, were grouped under "other indications". Warfarin was the most prescribed oral anticoagulant among the participants, corroborating the literature data (10, 22) .
In the present study the investigation was functioning, Vitality and General health status, the patients presented mean scores below 50, whereas in the present study, the values were above 60 (12) . A study performed with Argentinean patients (6) , although the more compromised domain was Pain, domains such as Physical functioning ( x = 50.0), Vitality ( x = 54.4) and General health status ( x =53.7) also had mean values below those found among the subjects of this study.
When comparing the measurements of HRQoL in relation to the age of the participants, statistically When comparing the HRQoL measurements according to gender, the men had higher scores than the women, in the majority of the domains of the SF-36, except for General health status. However, these differences were only statistically significant in the domains Mental health and Pain. Similar results were found in other studies (6, 20, 23) . It is believed that this could be due to the fact that men give less importance to healthcare, often delegating this responsibility to their wives.
Statistically significant differences were found for the measurements of the domains Physical aspects (p=0.04) and Physical functioning (p=0.03), presented in the three groups of patients classified according to clinical indication of the OAC. In this first domain, the patients with an indication due to the use of metallic prosthetic heart valve had better evaluations than the others. In the second domain, Physical functioning, the subjects with metallic prostheses also presented higher scores, followed by those with other clinical indications.
These results were also observed in a previous study (6) , in which the authors verified a better evaluation of the HRQoL in individuals with metallic prosthetic heart valves, compared to individuals diagnosed with atrial fibrillation.
HRQoL also differed when the subjects were evaluated according to duration of the use of OAC. A better HRQoL was verified among those in long-term treatment (over 10 years of use) and worse for those with short durations (less than one year). Other patients with less than one year of therapy also presented low SF-36 scores (6) . These results suggest that the relationship of HRQoL with the duration of OAC use may be related to the period of adaptation and change of habits resulting from the therapy, in the initial months of the treatment.
Thus, individuals with longer use could have already adapted, with regard to changing eating habits and behavior, as well as to the dosage and possible collateral effects of the medication.
Conclusion
The 
